Literature DB >> 8473751

Diverse T cell receptor V beta gene usage in the central nervous system in experimental allergic encephalomyelitis.

R B Bell1, J W Lindsey, R A Sobel, S Hodgkinson, L Steinman.   

Abstract

The repertoire of TCR V beta genes transcribed and expressed within the central nervous system was determined in mice with experimental allergic encephalomyelitis. Disease was induced in (PL/J x SJL/)F1 mice by immunizing with myelin basic protein-acetylated peptide 1-11, and mice were sacrificed at intervals from day 3 postimmunization to 3 wk after recovery from disease. Transcription of V beta genes was determined by reverse transcriptase polymerase chain reaction on RNA extracted from spinal cord, and expression of the V beta gene products was detected by immunohistochemistry with mAb specific for various V beta proteins. Multiple V beta genes were found to be transcribed and expressed in the central nervous system starting 7 days after immunization, and continuing up to 3 wk after clinical recovery. Preferential utilization of a single TCR V beta gene was not detected in the central nervous system at any time in the course of disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8473751

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry.

Authors:  L Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

2.  Recruitment of multiple V beta genes in the TCR repertoire against a single pathogenic thyroglobulin epitope.

Authors:  V P Rao; R S Russell; G Carayanniotis
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

3.  Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment.

Authors:  S Brocke; C Piercy; L Steinman; I L Weissman; T Veromaa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

4.  Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema.

Authors:  Andrew K Sullivan; Philip L Simonian; Michael T Falta; John D Mitchell; Gregory P Cosgrove; Kevin K Brown; Brian L Kotzin; Norbert F Voelkel; Andrew P Fontenot
Journal:  Am J Respir Crit Care Med       Date:  2005-06-03       Impact factor: 21.405

5.  Oligoclonality of T cells in salivary glands of autoimmune MRL/lpr mice.

Authors:  K Skarstein; R Holmdahl; A C Johannessen; R Jonsson
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

6.  A public T cell clonotype within a heterogeneous autoreactive repertoire is dominant in driving EAE.

Authors:  Juscilene S Menezes; Peter van den Elzen; Jordan Thornes; Donald Huffman; Nathalie M Droin; Emanual Maverakis; Eli E Sercarz
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 7.  Molecular recognition theory and sense-antisense interaction: therapeutic applications in autoimmunity.

Authors:  Matthew Thomas Hardison; James Edwin Blalock
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

8.  Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE).

Authors:  V Kumar; K Stellrecht; E Sercarz
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

Review 9.  Experimental immunotherapies for multiple sclerosis.

Authors:  R Martin; H McFarland
Journal:  Springer Semin Immunopathol       Date:  1996

10.  Encephalitogenicity of myelin basic protein exon-2 peptide in mice.

Authors:  R B Fritz; M L Zhao
Journal:  J Neuroimmunol       Date:  1994-04       Impact factor: 3.478

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.